[1]
M. Długosz-Danecka, A. Jaroszyński, and W. Jurczak, “Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients”, OncoReview, vol. 8, no. 4(32), pp. 99-104, Dec. 2018.